These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 28796857)

  • 61. Sarcopenia impairs prognosis of patients with liver cirrhosis.
    Hanai T; Shiraki M; Nishimura K; Ohnishi S; Imai K; Suetsugu A; Takai K; Shimizu M; Moriwaki H
    Nutrition; 2015 Jan; 31(1):193-9. PubMed ID: 25441595
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Prognostic value of preoperative neutrophil-to-lymphocyte ratio in the elderly patients over 75 years old with gastric cancer].
    Zhang X; Li S; Guo Z; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):526-9. PubMed ID: 27215519
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neutrophil-lymphocyte ratio is a simple and novel biomarker for prediction of survival after radioembolization for metastatic colorectal cancer.
    Tohme S; Sukato D; Chalhoub D; McDonald KA; Zajko A; Amesur N; Orons P; Marsh JW; Geller DA; Tsung A
    Ann Surg Oncol; 2015 May; 22(5):1701-7. PubMed ID: 25190128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer.
    Go SI; Park MJ; Song HN; Kang MH; Park HJ; Jeon KN; Kim SH; Kim MJ; Kang JH; Lee GW
    Support Care Cancer; 2016 May; 24(5):2075-2084. PubMed ID: 26546456
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer.
    Jankova L; Dent OF; Chan C; Chapuis P; Clarke SJ
    BMC Cancer; 2013 Oct; 13():442. PubMed ID: 24079717
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neutrophil-to-lymphocyte ratio and risk of lung cancer mortality in a low-risk population: A cohort study.
    Kang J; Chang Y; Ahn J; Oh S; Koo DH; Lee YG; Shin H; Ryu S
    Int J Cancer; 2019 Dec; 145(12):3267-3275. PubMed ID: 31454064
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sex Disparities in Outcomes of Early Stage Colorectal Cancer: A Population-Based Study.
    Samawi HH; Yin Y; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2018 Dec; 17(4):e711-e717. PubMed ID: 30120076
    [TBL] [Abstract][Full Text] [Related]  

  • 69.  Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis.
    Begini P; Gigante E; Antonelli G; Carbonetti F; Iannicelli E; Anania G; Imperatrice B; Pellicelli AM; Fave GD; Marignani M
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):107-114. PubMed ID: 28051799
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients.
    Yaprak M; Turan MN; Dayanan R; Akın S; Değirmen E; Yıldırım M; Turgut F
    Int Urol Nephrol; 2016 Aug; 48(8):1343-1348. PubMed ID: 27118565
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systemic inflammatory response predicts oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient colorectal cancer.
    Climent M; Ryan ÉJ; Stakelum Á; Khaw YL; Creavin B; Lloyd A; Alhassan D; Mohan HM; Kennelly R; Sheahan K; Winter DC
    Int J Colorectal Dis; 2019 Jun; 34(6):1069-1078. PubMed ID: 30993458
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer - A validation study.
    Smit KC; Derksen JWG; Kurk SA; Moeskops P; Koopman M; Veldhuis WB; May AM
    Clin Nutr ESPEN; 2024 Oct; 63():572-584. PubMed ID: 38997109
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Smoking and survival of colorectal cancer patients: population-based study from Germany.
    Walter V; Jansen L; Hoffmeister M; Ulrich A; Chang-Claude J; Brenner H
    Int J Cancer; 2015 Sep; 137(6):1433-45. PubMed ID: 25758762
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study).
    Caan BJ; Meyerhardt JA; Kroenke CH; Alexeeff S; Xiao J; Weltzien E; Feliciano EC; Castillo AL; Quesenberry CP; Kwan ML; Prado CM
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1008-1015. PubMed ID: 28506965
    [No Abstract]   [Full Text] [Related]  

  • 78. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.
    Neal CP; Cairns V; Jones MJ; Masood MM; Nana GR; Mann CD; Garcea G; Dennison AR
    Med Oncol; 2015 May; 32(5):144. PubMed ID: 25807934
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer.
    Jia J; Zheng X; Chen Y; Wang L; Lin L; Ye X; Chen Y; Chen D; Dettke M
    Tumour Biol; 2015 Dec; 36(12):9319-25. PubMed ID: 26104767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.